MELANIE MALONE: Open Payments
NPI 1851473102 · RUSSELLVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 108 payments from 18 companies in 2025. Trend: 2023 $1,922 · 2024 $2,021 · 2025 $1,889
Food & beverage: $1,889
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $370 |
| ABBVIE INC. | 38 | $355 |
| Novo Nordisk Inc | 10 | $263 |
| Lilly USA, LLC | 11 | $175 |
| AstraZeneca Pharmaceuticals LP | 4 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $104 |
| PFIZER INC. | 5 | $97 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
| Amgen Inc. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $57 |
Products named: CAPLYTA, Ozempic, VRAYLAR, FARXIGA, XIFAXAN, QULIPTA, MOUNJARO, UBRELVY.
Industry payments across AL — which companies pay providers there.
